241 related articles for article (PubMed ID: 240033)
1. Loss of marrow allograft resistance in mice with transplanted methylcholanthrene-induced sarcomas.
Kumar V; Bennett M
J Natl Cancer Inst; 1975 Aug; 55(2):489-92. PubMed ID: 240033
[TBL] [Abstract][Full Text] [Related]
2. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
Flood PM
J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
[TBL] [Abstract][Full Text] [Related]
3. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
Coggin JH
Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
[TBL] [Abstract][Full Text] [Related]
4. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
[TBL] [Abstract][Full Text] [Related]
5. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.
Palathumpat V; Holm B; Dejbakhsh-Jones S; Strober S
J Immunol; 1992 May; 148(10):3319-26. PubMed ID: 1578152
[TBL] [Abstract][Full Text] [Related]
6. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
[TBL] [Abstract][Full Text] [Related]
7. Genetically determined resistance to foreign bone marrow transplantation in mice: characterization of the effector cells.
Miller SC
J Immunol; 1983 Jul; 131(1):92-7. PubMed ID: 6345669
[TBL] [Abstract][Full Text] [Related]
8. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
[TBL] [Abstract][Full Text] [Related]
9. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
Rembecki RM; Bennett M; Kumar V; Potter TA
J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
[TBL] [Abstract][Full Text] [Related]
10. Rapid rejection of H2k and H2k/b bone marrow cell grafts by CD8+ T cells and NK cells in irradiated mice.
Davenport C; Kumar V; Bennett M
J Immunol; 1995 Oct; 155(8):3742-9. PubMed ID: 7561078
[TBL] [Abstract][Full Text] [Related]
11. Immune response to an allogeneic progressively growing solid tumor.
Eggers AE
Cancer Res; 1976 Jun; 36(6):2085-9. PubMed ID: 773534
[TBL] [Abstract][Full Text] [Related]
12. Use of newborn liver cells as a murine model for cord blood cell transplantation.
Davenport C; Kumar V; Bennett M
J Immunol; 1993 Aug; 151(3):1597-605. PubMed ID: 8101544
[TBL] [Abstract][Full Text] [Related]
13. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
14. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: possible explanation for the mechanism of tolerance induction by portal vein injection.
Zhang Y; Yasumizu R; Sugiura K; Hashimoto F; Amoh Y; Lian Z; Cherry ; Nishio N; Ikehara S
Eur J Immunol; 1994 Jul; 24(7):1558-65. PubMed ID: 7913037
[TBL] [Abstract][Full Text] [Related]
15. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
16. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
17. Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice.
Svane IM; Engel AM; Nielsen MB; Ljunggren HG; Rygaard J; Werdelin O
Eur J Immunol; 1996 Aug; 26(8):1844-50. PubMed ID: 8765030
[TBL] [Abstract][Full Text] [Related]
18. Leukemoid reaction in BALB/c mice bearing primary tumors induced by 3-methylcholanthrene.
Kodama T; Kawamura T; Kobayashi H
Cancer Res; 1978 Mar; 38(3):713-5. PubMed ID: 626975
[TBL] [Abstract][Full Text] [Related]
19. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
Hao J; Liu J; Xie S
Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
Cohen P; Vourka-Karussis U; Weiss L; Slavin S
J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]